Jump to section
To benefit health and humanity, radically transforming how the world uses lab spaces by delivering customized labs that deploy within weeks, and can grow and change as quickly as research needs evolve.
Today's biopharma landscape brims with promising new therapies, but scaling them comes with various challenges. Rigid lab infrastructure, tight funding markets, and the rapid pace of scientific advancement all conspire to stifle innovation.
Enter SmartLabs, a platform tackling these issues head-on. It offers "Labs as a Service", with fully resourced research environments that flex and adapt alongside project needs. This dynamic approach allows companies to launch, scale, and pivot seamlessly, saving vital time and capital.
With recent funding, SmartLabs is poised for explosive growth. The investment validates its disruptive model and fuels its expansion across the US. With a bold vision and substantial backing, SmartLabs is redefining the way we do science, making the future of scientific discovery a brighter space.
Freddie
Company Specialist at Welcome to the Jungle
Jan 2024
$48m
SERIES C
Sep 2021
$250m
SERIES B
Seth Taylor
(CBO)Founded BiotechTuesday in 2002. They also served as a Principal at TSG Parnter and Managing General Partner at Vectur LLC.